-->

Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 8, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 7, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 2, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 2, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 24, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 18, 2008View HTMLDownload DOCDownload PDF
CT ORDERConfidential treatment orderJun 17, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 5, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 3, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 3, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 3, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2008View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-150      151-152

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information